{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:34:23Z","timestamp":1790638463908,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":46,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Sponsored by Longyan City Science and Technology Plan Project","award":["2024LYF17040"],"award-info":[{"award-number":["2024LYF17040"]}]},{"name":"Startup Fund for Scientific Research, Fujian Medical University","award":["2022QH1344"],"award-info":[{"award-number":["2022QH1344"]}]},{"name":"Fujian Province Natural Science Foundation","award":["2023J011886"],"award-info":[{"award-number":["2023J011886"]}]},{"name":"Longyan City Science and Technology Plan Project","award":["2025LYF17050"],"award-info":[{"award-number":["2025LYF17050"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-44741-9","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T02:06:17Z","timestamp":1773972377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic and prognostic value of serum miR-155 in chronic obstructive pulmonary disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Yongming","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaodi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongzhang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"44741_CR1","unstructured":"disease Gifcol. Global strategy for the diagnosis, management, andprevention of chronic obstructive pulmonary disease(2023 REPORT)  (2022). https:\/\/goldcopd.org\/archived-reports\/ (accessed 15 Nov 2022)."},{"key":"44741_CR2","doi-asserted-by":"publisher","unstructured":"Li, M. et al. Burden of COPD in China and the global from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019. BMJ Open. Respir. Res. 10 (1). https:\/\/doi.org\/10.1136\/bmjresp-2023-001698 (2023).","DOI":"10.1136\/bmjresp-2023-001698"},{"issue":"12","key":"44741_CR3","doi-asserted-by":"publisher","first-page":"e2346598","DOI":"10.1001\/jamanetworkopen.2023.46598","volume":"6","author":"E Boers","year":"2023","unstructured":"Boers, E. et al. Global burden of chronic obstructive pulmonary disease through 2050. JAMA Netw. Open. 6 (12), e2346598. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.46598 (2023).","journal-title":"JAMA Netw. Open."},{"issue":"8","key":"44741_CR4","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/resp.12642","volume":"20","author":"NA Negewo","year":"2015","unstructured":"Negewo, N. A., Gibson, P. G. & McDonald, V. M. COPD and its comorbidities: Impact, measurement and mechanisms. Respirol. (Carlton Vic). 20 (8), 1160\u20131171. https:\/\/doi.org\/10.1111\/resp.12642 (2015).","journal-title":"Respirol. (Carlton Vic)"},{"key":"44741_CR5","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2147\/copd.S98333","volume":"11","author":"S Santos","year":"2016","unstructured":"Santos, S. et al. Treatment of patients with COPD and recurrent exacerbations: The role of infection and inflammation. Int. J. Chronic Obstr. Pulm. Dis. 11, 515\u2013525. https:\/\/doi.org\/10.2147\/copd.S98333 (2016).","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"issue":"1","key":"44741_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jaci.2016.05.011","volume":"138","author":"PJ Barnes","year":"2016","unstructured":"Barnes, P. J. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J. Allergy Clin. Immunol. 138 (1), 16\u201327. https:\/\/doi.org\/10.1016\/j.jaci.2016.05.011 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"44741_CR7","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1183\/09031936.06.00109605","volume":"27","author":"JP de Torres","year":"2006","unstructured":"de Torres, J. P. et al. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur. Respir. J. 27 (5), 902\u2013907. https:\/\/doi.org\/10.1183\/09031936.06.00109605 (2006).","journal-title":"Eur. Respir. J."},{"key":"44741_CR8","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ceb.2020.08.015","volume":"67","author":"H Galagali","year":"2020","unstructured":"Galagali, H. & Kim, J. K. The multifaceted roles of microRNAs in differentiation. Curr. Opin. Cell Biol. 67, 118\u2013140. https:\/\/doi.org\/10.1016\/j.ceb.2020.08.015 (2020).","journal-title":"Curr. Opin. Cell Biol."},{"issue":"1","key":"44741_CR9","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/s41467-017-00972-z","volume":"8","author":"M Mann","year":"2017","unstructured":"Mann, M. et al. An NF-\u03baB-microRNA regulatory network tunes macrophage inflammatory responses. Nat. Commun. 8 (1), 851. https:\/\/doi.org\/10.1038\/s41467-017-00972-z (2017).","journal-title":"Nat. Commun."},{"issue":"8","key":"44741_CR10","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.freeradbiomed.2012.01.031","volume":"52","author":"Y Zheng","year":"2012","unstructured":"Zheng, Y. et al. Glucocorticoids inhibit lipopolysaccharide-mediated inflammatory response by downregulating microRNA-155: a novel anti-inflammation mechanism. Free Radic. Biol. Med. 52 (8), 1307\u20131317. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2012.01.031 (2012).","journal-title":"Free Radic. Biol. Med."},{"issue":"8","key":"44741_CR11","doi-asserted-by":"publisher","first-page":"e71342","DOI":"10.1371\/journal.pone.0071342","volume":"8","author":"YC Kuo","year":"2013","unstructured":"Kuo, Y. C. et al. Human mesenchymal stem cells suppress the stretch-induced inflammatory miR-155 and cytokines in bronchial epithelial cells. PLoS One. 8 (8), e71342. https:\/\/doi.org\/10.1371\/journal.pone.0071342 (2013).","journal-title":"PLoS One"},{"issue":"3","key":"44741_CR12","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41385-019-0241-6","volume":"13","author":"EG De Smet","year":"2020","unstructured":"De Smet, E. G. et al. The role of miR-155 in cigarette smoke-induced pulmonary inflammation and COPD. Mucosal Immunol. 13 (3), 423\u2013436. https:\/\/doi.org\/10.1038\/s41385-019-0241-6 (2020).","journal-title":"Mucosal Immunol."},{"key":"44741_CR13","doi-asserted-by":"publisher","unstructured":"Song, J., Wang, Q. & Zong, L. LncRNA MIR155HG contributes to smoke-related chronic obstructive pulmonary disease by targeting miR-128-5p\/BRD4 axis. Biosci. Rep. 40 (3). https:\/\/doi.org\/10.1042\/bsr20192567 (2020).","DOI":"10.1042\/bsr20192567"},{"issue":"5\u20136","key":"44741_CR14","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.ijmm.2014.04.005","volume":"304","author":"M Das Gupta","year":"2014","unstructured":"Das Gupta, M. et al. Aspergillus fumigatus induces microRNA-132 in human monocytes and dendritic cells. Int. J. Med. Microbiol. IJMM. 304 (5\u20136), 592\u2013596. https:\/\/doi.org\/10.1016\/j.ijmm.2014.04.005 (2014).","journal-title":"Int. J. Med. Microbiol. IJMM"},{"issue":"7","key":"44741_CR15","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1631\/jzus.B2000826","volume":"22","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. Opposite effects of miR-155 in the initial and later stages of lipopolysaccharide (LPS)-induced inflammatory response. J. Zhejiang Univ. Sci. B. 22 (7), 590\u2013598. https:\/\/doi.org\/10.1631\/jzus.B2000826 (2021).","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"44741_CR16","doi-asserted-by":"crossref","unstructured":"Bulpa, P., Dive, A. & Sibille, Y. J. E. R. J. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. ;30(4), 782\u2013800 (2007).","DOI":"10.1183\/09031936.00062206"},{"key":"44741_CR17","doi-asserted-by":"publisher","unstructured":"Xu, H. et al. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: A case control study from China. Clin. Microbiol. Infect. 18(4), 403\u2013408. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03503.x (2012).","DOI":"10.1111\/j.1469-0691.2011.03503.x"},{"issue":"5","key":"44741_CR18","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10495-015-1098-0","volume":"20","author":"M Bodas","year":"2015","unstructured":"Bodas, M., Min, T. & Vij, N. Lactosylceramide-accumulation in lipid-rafts mediate aberrant-autophagy, inflammation and apoptosis in cigarette smoke induced emphysema. Apoptosis Int. J. Progr. Cell. Death. 20 (5), 725\u2013739. https:\/\/doi.org\/10.1007\/s10495-015-1098-0 (2015).","journal-title":"Apoptosis Int. J. Progr. Cell. Death"},{"issue":"22","key":"44741_CR19","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1001\/jama.2013.5732","volume":"309","author":"M Thomsen","year":"2013","unstructured":"Thomsen, M. et al. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. JAMA 309 (22), 2353\u20132361. https:\/\/doi.org\/10.1001\/jama.2013.5732 (2013).","journal-title":"JAMA"},{"issue":"6","key":"44741_CR20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.bbadis.2009.02.013","volume":"1792","author":"I Faraoni","year":"2009","unstructured":"Faraoni, I., Antonetti, F. R., Cardone, J. & Bonmassar, E. miR-155 gene: A typical multifunctional microRNA. Biochim. Biophys. Acta. 1792 (6), 497\u2013505. https:\/\/doi.org\/10.1016\/j.bbadis.2009.02.013 (2009).","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"44741_CR21","doi-asserted-by":"publisher","first-page":"12871","DOI":"10.1038\/s41598-017-13265-8","volume":"7","author":"G Conickx","year":"2017","unstructured":"Conickx, G. et al. microRNA profiling in lung tissue and bronchoalveolar lavage of cigarette smoke-exposed mice and in COPD patients: A translational approach. Sci. Rep. 7 (1), 12871. https:\/\/doi.org\/10.1038\/s41598-017-13265-8 (2017).","journal-title":"Sci. Rep."},{"key":"44741_CR22","doi-asserted-by":"publisher","first-page":"156662","DOI":"10.1016\/j.cyto.2024.156662","volume":"180","author":"K Tian","year":"2024","unstructured":"Tian, K., Xu, W., Chen, M. & Deng, F. miR-155 promotes Th17 differentiation by targeting FOXP3 to aggravate inflammation in MRSA pneumonia. Cytokine 180, 156662. https:\/\/doi.org\/10.1016\/j.cyto.2024.156662 (2024).","journal-title":"Cytokine"},{"key":"44741_CR23","doi-asserted-by":"publisher","unstructured":"Blomme, E. E. et al. Innate lymphoid cells in isocyanate-induced asthma: role of microRNA-155. Eur. Respir. J. 56 (3). https:\/\/doi.org\/10.1183\/13993003.01289-2019 (2020).","DOI":"10.1183\/13993003.01289-2019"},{"issue":"1","key":"44741_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13075-016-1054-6","volume":"18","author":"RB Christmann","year":"2016","unstructured":"Christmann, R. B. et al. miR-155 in the progression of lung fibrosis in systemic sclerosis. Arthritis Res. Ther. 18 (1), 155. https:\/\/doi.org\/10.1186\/s13075-016-1054-6 (2016).","journal-title":"Arthritis Res. Ther."},{"issue":"12","key":"44741_CR25","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s00011-022-01643-6","volume":"71","author":"WD Xu","year":"2022","unstructured":"Xu, W. D., Feng, S. Y. & Huang, A. F. Role of miR-155 in inflammatory autoimmune diseases: A comprehensive review. Inflamm. Res. 71 (12), 1501\u20131517. https:\/\/doi.org\/10.1007\/s00011-022-01643-6 (2022).","journal-title":"Inflamm. Res."},{"issue":"29","key":"44741_CR26","doi-asserted-by":"publisher","first-page":"e2408649121","DOI":"10.1073\/pnas.2408649121","volume":"121","author":"E Tili","year":"2024","unstructured":"Tili, E. et al. MiR-155-targeted IcosL controls tumor rejection. Proc. Natl. Acad. Sci. U.S.A. 121 (29), e2408649121. https:\/\/doi.org\/10.1073\/pnas.2408649121 (2024).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"44741_CR27","doi-asserted-by":"publisher","unstructured":"Wedzicha, J. A. E. C. C. et al. Management of COPD exacerbations: A European Respiratory Society\/American Thoracic Society guideline. Eur. Respir. J. 49 (3). https:\/\/doi.org\/10.1183\/13993003.00791-2016 (2017).","DOI":"10.1183\/13993003.00791-2016"},{"issue":"11","key":"44741_CR28","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1164\/rccm.202108-1819PP","volume":"204","author":"BR Celli","year":"2021","unstructured":"Celli, B. R. et al. An updated definition and severity classification of chronic obstructive pulmonary disease exacerbations: The Rome proposal. Am. J. Respir. Crit. Care Med. 204 (11), 1251\u20131258. https:\/\/doi.org\/10.1164\/rccm.202108-1819PP (2021).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"44741_CR29","unstructured":"Obstruc. Gifc. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary\u2026 Disease (2022 Report). LULU com (2021)."},{"issue":"12","key":"44741_CR30","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.3760\/cma.j.issn.0366-6999.20122974","volume":"126","author":"F Ye","year":"2013","unstructured":"Ye, F. et al. Spectrum and antimicrobial resistance of common pathogenic bacteria isolated from patients with acute exacerbation of chronic obstructive pulmonary disease in mainland of China. Chin. Med. J. 126 (12), 2207\u20132214 (2013).","journal-title":"Chin. Med. J."},{"key":"44741_CR31","doi-asserted-by":"publisher","unstructured":"Pieri, M., Vayianos, P., Nicolaidou, V., Felekkis, K. & Papaneophytou, C. Alterations in circulating miRNA levels after infection with SARS-CoV-2 could contribute to the development of cardiovascular diseases: What we know so far. Int. J. Mol. Sci. 24 (3). https:\/\/doi.org\/10.3390\/ijms24032380 (2023).","DOI":"10.3390\/ijms24032380"},{"issue":"4","key":"44741_CR32","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.ajpath.2016.12.012","volume":"187","author":"DA Pociask","year":"2017","unstructured":"Pociask, D. A. et al. Epigenetic and transcriptomic regulation of lung repair during recovery from influenza infection. Am. J. Pathol. 187 (4), 851\u2013863. https:\/\/doi.org\/10.1016\/j.ajpath.2016.12.012 (2017).","journal-title":"Am. J. Pathol."},{"key":"44741_CR33","doi-asserted-by":"publisher","unstructured":"Savino, F. et al. Peripheral blood and nasopharyngeal swab MiRNA-155 expression in infants with respiratory syncytial virus infection. Viruses. 15 (8). https:\/\/doi.org\/10.3390\/v15081668 (2023).","DOI":"10.3390\/v15081668"},{"issue":"7","key":"44741_CR34","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1128\/iai.01666-14","volume":"82","author":"R Rao","year":"2014","unstructured":"Rao, R., Rieder, S. A., Nagarkatti, P. & Nagarkatti, M. Staphylococcal enterotoxin B-induced microRNA-155 targets SOCS1 to promote acute inflammatory lung injury. Infect. Immun. 82 (7), 2971\u20132979. https:\/\/doi.org\/10.1128\/iai.01666-14 (2014).","journal-title":"Infect. Immun."},{"issue":"5","key":"44741_CR35","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1007\/s10753-018-0811-x","volume":"41","author":"Z Meiqian","year":"2018","unstructured":"Meiqian, Z., Leying, Z. & Chang, C. Astragaloside IV inhibits cigarette smoke-induced pulmonary inflammation in mice. Inflammation. 41 (5), 1671\u20131680. https:\/\/doi.org\/10.1007\/s10753-018-0811-x (2018).","journal-title":"Inflammation"},{"key":"44741_CR36","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2147\/copd.S188139","volume":"14","author":"YY Zeng","year":"2019","unstructured":"Zeng, Y. Y., Hu, W. P., Zuo, Y. H., Wang, X. R. & Zhang, J. Altered serum levels of type I collagen turnover indicators accompanied by IL-6 and IL-8 release in stable COPD. Int. J. Chronic Obstr. Pulm. Dis. 14, 163\u2013168. https:\/\/doi.org\/10.2147\/copd.S188139 (2019).","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"issue":"1","key":"44741_CR37","doi-asserted-by":"publisher","first-page":"8779","DOI":"10.1038\/s41598-024-59321-y","volume":"14","author":"B \u015awi\u0105tkowska","year":"2024","unstructured":"\u015awi\u0105tkowska, B., Jankowski, M. & Kaleta, D. Comparative evaluation of ten blood biomarkers of inflammation in regular heated tobacco users and non-smoking healthy males-a pilot study. Sci. Rep. 14 (1), 8779. https:\/\/doi.org\/10.1038\/s41598-024-59321-y (2024).","journal-title":"Sci. Rep."},{"issue":"1","key":"44741_CR38","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1183\/09031936.03.00093703","volume":"22","author":"IS Patel","year":"2003","unstructured":"Patel, I. S., Roberts, N. J., Lloyd-Owen, S. J., Sapsford, R. J. & Wedzicha, J. A. Airway epithelial inflammatory responses and clinical parameters in COPD. Eur. Respir. J. 22 (1), 94\u201399. https:\/\/doi.org\/10.1183\/09031936.03.00093703 (2003).","journal-title":"Eur. Respir. J."},{"issue":"5","key":"44741_CR39","first-page":"737","volume":"74","author":"Y Chen","year":"2022","unstructured":"Chen, Y., Li, M. J., Wang, W. S., Ye, B. C. & Qiu, C. H. Effect and mechanism of microRNA-155 in chronic obstructive pulmonary disease by targeting PIK3R1. Sheng li xue bao: [Acta Physiol. Sinica]. 74 (5), 737\u2013750 (2022).","journal-title":"Sheng li xue bao: [Acta Physiol. Sinica]"},{"issue":"11","key":"44741_CR40","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1164\/rccm.200709-1356OC","volume":"177","author":"DD Sin","year":"2008","unstructured":"Sin, D. D. et al. The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease. Am. J. Respir. Crit Care Med. 177 (11), 1207\u20131214. https:\/\/doi.org\/10.1164\/rccm.200709-1356OC (2008).","journal-title":"Am. J. Respir. Crit Care Med."},{"issue":"10","key":"44741_CR41","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa021322","volume":"350","author":"BR Celli","year":"2004","unstructured":"Celli, B. R. et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N. Engl. J. Med. 350 (10), 1005\u20131012. https:\/\/doi.org\/10.1056\/NEJMoa021322 (2004).","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"44741_CR42","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1164\/rccm.201603-0622OC","volume":"195","author":"FJ Martinez","year":"2017","unstructured":"Martinez, F. J. et al. A new approach for identifying patients with undiagnosed chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 195 (6), 748\u2013756. https:\/\/doi.org\/10.1164\/rccm.201603-0622OC (2017).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"44741_CR43","doi-asserted-by":"publisher","first-page":"e032467","DOI":"10.1136\/bmjopen-2019-032467","volume":"10","author":"P Stone","year":"2020","unstructured":"Stone, P., Sood, N., Feary, J., Roberts, C. M. & Quint, J. K. Validation of acute exacerbation of chronic obstructive pulmonary disease (COPD) recording in electronic health records: A systematic review protocol. BMJ Open. 10 (2), e032467. https:\/\/doi.org\/10.1136\/bmjopen-2019-032467 (2020).","journal-title":"BMJ Open."},{"issue":"12","key":"44741_CR44","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","volume":"363","author":"JR Hurst","year":"2010","unstructured":"Hurst, J. R. et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N. Engl. J. Med. 363 (12), 1128\u20131138. https:\/\/doi.org\/10.1056\/NEJMoa0909883 (2010).","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"44741_CR45","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1136\/thoraxjnl-2019-214484","volume":"75","author":"AG Mathioudakis","year":"2020","unstructured":"Mathioudakis, A. G. et al. Acute exacerbations of chronic obstructive pulmonary disease: in search of diagnostic biomarkers and treatable traits. Thorax 75 (6), 520\u2013527. https:\/\/doi.org\/10.1136\/thoraxjnl-2019-214484 (2020).","journal-title":"Thorax"},{"issue":"2","key":"44741_CR46","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.numecd.2011.04.006","volume":"23","author":"M Koz\u00e0kov\u00e0","year":"2013","unstructured":"Koz\u00e0kov\u00e0, M. et al. Gender-specific differences in carotid intima-media thickness and its progression over three years: a multicenter European study. Nutrition, metabolism, and cardiovascular diseases. NMCD 23 (2), 151\u2013158. https:\/\/doi.org\/10.1016\/j.numecd.2011.04.006 (2013).","journal-title":"NMCD"},{"issue":"14","key":"44741_CR47","first-page":"2594","volume":"127","author":"R Zhang","year":"2014","unstructured":"Zhang, R. et al. Comparison of symptom and risk assessment methods among patients with chronic obstructive pulmonary disease. Chin. Med. J. 127 (14), 2594\u20132598 (2014).","journal-title":"Chin. Med. J."},{"key":"44741_CR48","doi-asserted-by":"publisher","first-page":"569","DOI":"10.2147\/copd.S344669","volume":"17","author":"A L\u00f8kke","year":"2022","unstructured":"L\u00f8kke, A. et al. Disease trajectories and impact of one moderate exacerbation in Gold B COPD patients. Int. J. Chronic Obstr. Pulm. Dis. 17, 569\u2013578. https:\/\/doi.org\/10.2147\/copd.S344669 (2022).","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44741-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44741-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44741-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T23:56:26Z","timestamp":1777938986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44741-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["44741"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-44741-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"assertion":[{"value":"29 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The blood samples of participants used in this study were approved by the Ethics Committee of Longyan First Affiliated Hospital of Fujian Medical University (approval no. LYREC2023-k066-01, LYREC2023-k067-01, and no. LYREC2025-k010-01). Written informed consent was obtained from all participants. All the research was conducted in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"14266"}}